Cargando…
Valacyclovir-Induced Thrombotic Thrombocytopenic Purpura
Valacyclovir is a well-tolerated antiviral drug. Thrombotic thrombocytopenic purpura is a rare adverse effect of valacyclovir therapy. Mostly, it has been reported in clinical trials and case reports in patients with high dose or low dose therapy in immunocompromised patients. Herein we write a case...
Autores principales: | Bukhari, Sumera, Aslam, Hafiz M, Awwal, Talha A, Christmas, Donald, Wallach, Sara L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294875/ https://www.ncbi.nlm.nih.gov/pubmed/32550073 http://dx.doi.org/10.7759/cureus.8156 |
Ejemplares similares
-
A Case of COVID-19 Induced Thrombotic Thrombocytopenic Purpura
por: Shankar, Karthik, et al.
Publicado: (2021) -
Dengue Infection Triggering Concurrent Thrombotic Thrombocytopenic Purpura in a Case of Chronic Idiopathic Thrombocytopenic Purpura
por: Rana, Akash, et al.
Publicado: (2023) -
Suspected Metformin-induced Cobalamin Deficiency Mimicking Thrombotic Thrombocytopenic Purpura
por: Hussain, Syed Ather, et al.
Publicado: (2020) -
Refractory Thrombotic Thrombocytopenic Purpura to Therapeutic Plasma Exchange
por: Kiamos, Amy, et al.
Publicado: (2022) -
Role of the PLASMIC Score in the Management of Thrombotic Thrombocytopenic Purpura
por: Vyas, Abhinav, et al.
Publicado: (2023)